Dynamics of Co-Infection with Bartonella henselae Genotypes I and II in Naturally Infected Cats: Implications for Feline Vaccine Development

Camille Huwyler, Nadja Heiniger, Bruno B Chomel, Minsoo Kim, Rickie W. Kasten, Jane E. Koehler

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Bartonella henselae is an emerging bacterial pathogen causing cat-scratch disease and potentially fatal bacillary angiomatosis in humans. Bacteremic cats constitute a large reservoir for human infection. Although feline vaccination is a potential strategy to prevent human infection, selection of appropriate B. henselae strains is critical for successful vaccine development. Two distinct genotypes of B. henselae (type I, type II) have been identified and are known to co-infect the feline host, but very little is known about the interaction of these two genotypes during co-infection in vivo. To study the in vivo dynamics of type I and type II co-infection, we evaluated three kittens that were naturally flea-infected with both B. henselae type I and type II. Fifty individual bloodstream isolates from each of the cats over multiple time points were molecularly typed (by 16S rRNA gene sequencing), to determine the prevalence of the two genotypes over 2 years of persistent infection. We found that both B. henselae genotypes were transmitted simultaneously to each cat via natural flea infestation, resulting in mixed infection with both genotypes. Although the initial infection was predominately type I, after the first 2 months, the isolated genotype shifted to exclusively type II, which then persisted with a relapsing pattern. Understanding the parameters of protection against both genotypes of B. henselae, and the competitive dynamics in vivo between the two genotypes, will be critical in the development of a successful feline vaccine that can ultimately prevent B. henselae transmission to human contacts.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalMicrobial Ecology
DOIs
StateAccepted/In press - Feb 2 2017

Fingerprint

Bartonella henselae
vaccine development
vaccine
mixed infection
genotype
cats
flea
Siphonaptera
infection
cat scratch disease
kittens
vaccination
in vivo studies
blood flow
pathogen
ribosomal RNA
vaccines
gene
pathogens

Keywords

  • Bartonella henselae
  • Feline bacteremia
  • Genotypes
  • hbpA
  • Vaccine

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Ecology
  • Soil Science

Cite this

Dynamics of Co-Infection with Bartonella henselae Genotypes I and II in Naturally Infected Cats : Implications for Feline Vaccine Development. / Huwyler, Camille; Heiniger, Nadja; Chomel, Bruno B; Kim, Minsoo; Kasten, Rickie W.; Koehler, Jane E.

In: Microbial Ecology, 02.02.2017, p. 1-11.

Research output: Contribution to journalArticle

@article{c8d7da04a5ed4360897346297d43cc15,
title = "Dynamics of Co-Infection with Bartonella henselae Genotypes I and II in Naturally Infected Cats: Implications for Feline Vaccine Development",
abstract = "Bartonella henselae is an emerging bacterial pathogen causing cat-scratch disease and potentially fatal bacillary angiomatosis in humans. Bacteremic cats constitute a large reservoir for human infection. Although feline vaccination is a potential strategy to prevent human infection, selection of appropriate B. henselae strains is critical for successful vaccine development. Two distinct genotypes of B. henselae (type I, type II) have been identified and are known to co-infect the feline host, but very little is known about the interaction of these two genotypes during co-infection in vivo. To study the in vivo dynamics of type I and type II co-infection, we evaluated three kittens that were naturally flea-infected with both B. henselae type I and type II. Fifty individual bloodstream isolates from each of the cats over multiple time points were molecularly typed (by 16S rRNA gene sequencing), to determine the prevalence of the two genotypes over 2 years of persistent infection. We found that both B. henselae genotypes were transmitted simultaneously to each cat via natural flea infestation, resulting in mixed infection with both genotypes. Although the initial infection was predominately type I, after the first 2 months, the isolated genotype shifted to exclusively type II, which then persisted with a relapsing pattern. Understanding the parameters of protection against both genotypes of B. henselae, and the competitive dynamics in vivo between the two genotypes, will be critical in the development of a successful feline vaccine that can ultimately prevent B. henselae transmission to human contacts.",
keywords = "Bartonella henselae, Feline bacteremia, Genotypes, hbpA, Vaccine",
author = "Camille Huwyler and Nadja Heiniger and Chomel, {Bruno B} and Minsoo Kim and Kasten, {Rickie W.} and Koehler, {Jane E.}",
year = "2017",
month = "2",
day = "2",
doi = "10.1007/s00248-017-0936-8",
language = "English (US)",
pages = "1--11",
journal = "Microbial Ecology",
issn = "0095-3628",
publisher = "Springer New York",

}

TY - JOUR

T1 - Dynamics of Co-Infection with Bartonella henselae Genotypes I and II in Naturally Infected Cats

T2 - Implications for Feline Vaccine Development

AU - Huwyler, Camille

AU - Heiniger, Nadja

AU - Chomel, Bruno B

AU - Kim, Minsoo

AU - Kasten, Rickie W.

AU - Koehler, Jane E.

PY - 2017/2/2

Y1 - 2017/2/2

N2 - Bartonella henselae is an emerging bacterial pathogen causing cat-scratch disease and potentially fatal bacillary angiomatosis in humans. Bacteremic cats constitute a large reservoir for human infection. Although feline vaccination is a potential strategy to prevent human infection, selection of appropriate B. henselae strains is critical for successful vaccine development. Two distinct genotypes of B. henselae (type I, type II) have been identified and are known to co-infect the feline host, but very little is known about the interaction of these two genotypes during co-infection in vivo. To study the in vivo dynamics of type I and type II co-infection, we evaluated three kittens that were naturally flea-infected with both B. henselae type I and type II. Fifty individual bloodstream isolates from each of the cats over multiple time points were molecularly typed (by 16S rRNA gene sequencing), to determine the prevalence of the two genotypes over 2 years of persistent infection. We found that both B. henselae genotypes were transmitted simultaneously to each cat via natural flea infestation, resulting in mixed infection with both genotypes. Although the initial infection was predominately type I, after the first 2 months, the isolated genotype shifted to exclusively type II, which then persisted with a relapsing pattern. Understanding the parameters of protection against both genotypes of B. henselae, and the competitive dynamics in vivo between the two genotypes, will be critical in the development of a successful feline vaccine that can ultimately prevent B. henselae transmission to human contacts.

AB - Bartonella henselae is an emerging bacterial pathogen causing cat-scratch disease and potentially fatal bacillary angiomatosis in humans. Bacteremic cats constitute a large reservoir for human infection. Although feline vaccination is a potential strategy to prevent human infection, selection of appropriate B. henselae strains is critical for successful vaccine development. Two distinct genotypes of B. henselae (type I, type II) have been identified and are known to co-infect the feline host, but very little is known about the interaction of these two genotypes during co-infection in vivo. To study the in vivo dynamics of type I and type II co-infection, we evaluated three kittens that were naturally flea-infected with both B. henselae type I and type II. Fifty individual bloodstream isolates from each of the cats over multiple time points were molecularly typed (by 16S rRNA gene sequencing), to determine the prevalence of the two genotypes over 2 years of persistent infection. We found that both B. henselae genotypes were transmitted simultaneously to each cat via natural flea infestation, resulting in mixed infection with both genotypes. Although the initial infection was predominately type I, after the first 2 months, the isolated genotype shifted to exclusively type II, which then persisted with a relapsing pattern. Understanding the parameters of protection against both genotypes of B. henselae, and the competitive dynamics in vivo between the two genotypes, will be critical in the development of a successful feline vaccine that can ultimately prevent B. henselae transmission to human contacts.

KW - Bartonella henselae

KW - Feline bacteremia

KW - Genotypes

KW - hbpA

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85011301074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011301074&partnerID=8YFLogxK

U2 - 10.1007/s00248-017-0936-8

DO - 10.1007/s00248-017-0936-8

M3 - Article

C2 - 28150014

AN - SCOPUS:85011301074

SP - 1

EP - 11

JO - Microbial Ecology

JF - Microbial Ecology

SN - 0095-3628

ER -